ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
70,968.30
-0.67%
S&P 500
5,308.13
0.09%
Dow Jones
39,806.77
-0.49%
US Dollar vs Yen
156.1515
-0.14%
Brent Oil
82.835
-0.83%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. イギリス
  5. LSE
  6. Bayer Ord (BYR)

  7. Bayer Ord (BYR) ニュース

BYR

Bayer Ord (BYR)

Bayer Ord
から:
次の項目別のソート:
 Showing the most relevant articles for your search:LSE:BYR
日付受信時刻ニュースソース見出しコード企業名
2024/05/1418 : 15Alliance NewsAlliance NewsTOP NEWS: Bayer performs "as expected" with quarterly sales declineLSE:BYRBayer Ord
2024/03/0521 : 17Alliance NewsAlliance NewsUPDATE: Bayer denies split-up as "not now" while swings to annual lossLSE:BYRBayer Ord
2024/03/0519 : 13Alliance NewsAlliance NewsTOP NEWS: Bayer swings to annual loss on falling sales as costs riseLSE:BYRBayer Ord
2024/03/0418 : 35Alliance NewsAlliance NewsBayer acquires European marketing rights to acoramidis heart treatmentLSE:BYRBayer Ord
2024/02/2003 : 17Alliance NewsAlliance NewsTOP NEWS: Bayer slashes dividend in commitment to cutting down debtLSE:BYRBayer Ord
2024/02/1402 : 07Alliance NewsAlliance NewsIN BRIEF: Bayer notes first patient in GenePHIT trialLSE:BYRBayer Ord
2024/01/1815 : 09Alliance NewsAlliance NewsChemical firm Bayer confirms 'significant' workforce cuts in GermanyLSE:BYRBayer Ord
2024/01/1123 : 29Alliance NewsAlliance NewsCORRECT: RTW Biotech's manager invests USD127 million in Ji XingLSE:BYRBayer Ord
2024/01/0903 : 12Alliance NewsAlliance NewsBayer reports progress on two fronts for menopausal drug, elinzanetantLSE:BYRBayer Ord
2024/01/0821 : 27Alliance NewsAlliance NewsRTW Biotech Opportunities invests USD127 million in investee Ji XingLSE:BYRBayer Ord
2023/12/1914 : 52Alliance NewsAlliance NewsBayer's Monsanto to pay USD857 million over chemicals in schoolLSE:BYRBayer Ord
2023/11/2019 : 51Alliance NewsAlliance NewsTOP NEWS: Bayer stock plunges on study blow for blood thinnerLSE:BYRBayer Ord
2023/11/0817 : 40Alliance NewsAlliance NewsTOP NEWS: Bayer considers splitting up as quarterly loss balloonsLSE:BYRBayer Ord
2023/11/0121 : 41Alliance NewsAlliance NewsBayer loses third consecutive US damages trial over Roundup weedkillerLSE:BYRBayer Ord
2023/08/0816 : 03Alliance NewsAlliance NewsTOP NEWS: Bayer loss widens to nearly EUR2 billion on glyphosate hitLSE:BYRBayer Ord
2023/07/2504 : 26Alliance NewsAlliance NewsTOP NEWS: Bayer cuts guidance on lower prices of glyphosate productsLSE:BYRBayer Ord
2023/06/0519 : 39Alliance NewsAlliance NewsIN BRIEF: Bayer partners with Acquitas on lipid nanoparticle techLSE:BYRBayer Ord
2023/05/1120 : 21Alliance NewsAlliance NewsTOP NEWS: Bayer shares fall as sales suffer on lower pricingLSE:BYRBayer Ord
2023/02/2820 : 09Alliance NewsAlliance NewsBayer sees strong performance over 2022 but cautious over inflationLSE:BYRBayer Ord
2023/02/1019 : 54Alliance NewsAlliance NewsIN BRIEF: Bayer's Kerendia granted label update by European CommissionLSE:BYRBayer Ord
2023/02/0904 : 13Alliance NewsAlliance NewsTOP NEWS: Bayer appoints Bill Anderson as new chief executiveLSE:BYRBayer Ord
2023/01/2320 : 02Alliance NewsAlliance NewsBayer's Ultravist wins contrast-enhanced mammography approval in EULSE:BYRBayer Ord
2022/11/1020 : 10Alliance NewsAlliance NewsBayer buys German biotechnology start-up TargenomixLSE:BYRBayer Ord
2022/09/0914 : 40Alliance NewsAlliance NewsRegeneron shares surge on positive Eylea trial dataLSE:BYRBayer Ord
2022/08/1220 : 02Alliance NewsAlliance NewsTribunal rules against BASF in seed businesses dispute with BayerLSE:BYRBayer Ord
2022/08/0416 : 48Alliance NewsAlliance NewsTOP NEWS: Legal woes hit Bayer's profit in second quarterLSE:BYRBayer Ord
2022/06/2205 : 53Alliance NewsAlliance NewsUS high court denies Bayer bid to block Roundup weedkiller lawsuitsLSE:BYRBayer Ord
2022/05/1016 : 00Alliance NewsAlliance NewsTOP NEWS: Bayer makes good start to 2022 with strong quarterly salesLSE:BYRBayer Ord
2022/04/2220 : 16Alliance NewsAlliance NewsIN BRIEF: Bayer seeks further approval for darolutamide in ChinaLSE:BYRBayer Ord
2022/04/0503 : 09Alliance NewsAlliance NewsIN BRIEF: Bayer notes positive new data for finerenoneLSE:BYRBayer Ord
 Showing the most relevant articles for your search:LSE:BYR

最近閲覧した銘柄

NASDAQ
UMBF
UMB Financial
NASDAQ
CHKEW
Chesapeake Energy
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有